Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Royal Marsden NHS Foundation Trust
University of Iowa
National Cancer Institute (NCI)
Institut Bergonié
Eli Lilly and Company
Eli Lilly and Company
National Taiwan University Hospital
Shasqi, Inc.
Massachusetts General Hospital
Roswell Park Cancer Institute
ImmunoGenesis
Hutchmed
University of Washington
Columbia University
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
Cogent Biosciences, Inc.
Oncternal Therapeutics, Inc
BeiGene
Deciphera Pharmaceuticals, LLC
Immodulon Therapeutics Ltd
Mundipharma Research Limited
NantCell, Inc.
Fred Hutchinson Cancer Center
Children's Oncology Group
Hutchmed
University of Iowa
University of Iowa
Hutchmed
Theseus Pharmaceuticals
ImmunityBio, Inc.
Lumos Pharma
Cellestia Biotech AG
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Y-mAbs Therapeutics
Eli Lilly and Company
Eisai Inc.
Genmab
City of Hope Medical Center
Eisai Inc.
MaineHealth
M.D. Anderson Cancer Center
Rush University Medical Center
Bristol-Myers Squibb
Nektar Therapeutics